GLUTATHIONE CONTENT IN HUMAN BONE-MARROW AND CIRCADIAN STAGE RELATION TO DNA-SYNTHESIS

被引:35
作者
SMAALAND, R
SVARDAL, AM
LOTE, K
UELAND, PM
LAERUM, OD
机构
[1] UNIV BERGEN, HAUKELAND HOSP, DEPT PHARMACOL & TOXICOL, BERGEN, NORWAY
[2] UNIV BERGEN, HAUKELAND HOSP, DEPT PHARMACOL & TOXICOL, N-5021 BERGEN, NORWAY
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1991年 / 83卷 / 15期
关键词
D O I
10.1093/jnci/83.15.1092
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA synthesis and contents of reduced glutathione (GSH) and oxidized glutathione were determined every 4 hours during a 24-hour period in 70 human bone marrow samples from 10 healthy males. The mean GSH contents during the sampling periods were low, varying from 1.94 to 3.27 nmol/mg protein between the subjects; the mean values for all samples were 2.54 +/- 0.06 nmol/mg protein. The GSH content varied markedly within the individual according to circadian stage (31.0% to 90.2%; mean, 51.4%). Between individuals the mean percentage of cells in DNA synthesis varied from 10.6% to 14.5%, but there was an intraindividual circadian stage-dependent variation, ranging from 48.9% to 274.0% (mean, 126.6%), relative to the lowest value. After adjustment for a slight phase difference between GSH content and DNA synthesis observed for some of the subjects, a statistically significant correlation was found between the GSH content and the fraction of cells in DNA synthesis. The myelosuppressive effect of many chemotherapeutic agents assumed to be detoxified by GSH-dependent mechanism(s) should be considered in the light of the low GSH content in human bone marrow, the circadian variation of DNA synthesis, and the circadian stage-dependent relationship of the GSH content and DNA synthesis.
引用
收藏
页码:1092 / 1098
页数:7
相关论文
共 50 条
[1]   ENHANCED POTENTIATION OF CISPLATIN CYTO-TOXICITY IN HUMAN OVARIAN-CARCINOMA CELLS BY PROLONGED GLUTATHIONE DEPLETION [J].
ANDREWS, PA ;
SCHIEFER, MA ;
MURPHY, MP ;
HOWELL, SB .
CHEMICO-BIOLOGICAL INTERACTIONS, 1988, 65 (01) :51-58
[2]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].
ANTMAN, KS ;
GRIFFIN, JD ;
ELIAS, A ;
SOCINSKI, MA ;
RYAN, L ;
CANNISTRA, SA ;
OETTE, D ;
WHITLEY, M ;
FREI, E ;
SCHNIPPER, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598
[3]  
BEHRENS BC, 1987, CANCER RES, V47, P414
[4]   DAILY VARIATION IN NON-PROTEIN SULFHYDRYL LEVELS OF HUMAN-BONE MARROW [J].
BELLAMY, WT ;
ALBERTS, DS ;
DORR, RT .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (11) :1759-1762
[5]   THE ROLE OF THIOLS IN CELLULAR-RESPONSE TO RADIATION AND DRUGS [J].
BIAGLOW, JE ;
VARNES, ME ;
CLARK, EP ;
EPP, ER .
RADIATION RESEARCH, 1983, 95 (03) :437-455
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER [J].
BRONCHUD, MH ;
SCARFFE, JH ;
THATCHER, N ;
CROWTHER, D ;
SOUZA, LM ;
ALTON, NK ;
TESTA, NG ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1987, 56 (06) :809-813
[8]   THE USE OF DRUGS WHICH DEPLETE INTRACELLULAR GLUTATHIONE IN HYPOXIC CELL RADIOSENSITIZATION [J].
BUMP, EA ;
YU, NY ;
BROWN, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4) :439-442
[9]   AUTOLOGOUS BONE-MARROW TRANSPLANTATION - CURRENT STATUS AND FUTURE-DIRECTIONS [J].
CHESON, BD ;
LACERNA, L ;
LEYLANDJONES, B ;
SAROSY, G ;
WITTES, RE .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (01) :51-65
[10]  
CROOK TR, 1986, CANCER RES, V46, P5035